Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-11-29
2005-11-29
McKane, Joseph K. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S081000, C514S291000, C514S292000
Reexamination Certificate
active
06969721
ABSTRACT:
The present invention relates to tricyclic 2-pyridone compounds of formula (I):or stereoisomeric forms, stereoisomeric mixtures, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of HIV reverse transcriptase, and to pharmaceutical compositions and diagnostic kits comprising the same, and methods of using the same for treating viral infection or as an assay standard or reagent.
REFERENCES:
patent: 6030967 (2000-02-01), Marui et al.
patent: 2206674 (1972-08-01), None
patent: 4320347 (1994-12-01), None
patent: 4344452 (1995-06-01), None
patent: 0530994 (1993-03-01), None
patent: WO 92/06971 (1992-04-01), None
patent: 9207468 (1992-05-01), None
patent: 9512583 (1995-05-01), None
patent: 9814436 (1998-04-01), None
patent: WO 98/20867 (1998-05-01), None
patent: 9845276 (1998-10-01), None
patent: WO 00/29577 (2000-05-01), None
patent: 0129037 (2001-04-01), None
CAPLUS AN 2003:204695, abstract of Grivel et al, “Bystander CD4+ T lymphocytes survive in HIV-infected human lymphoid tissue.” AIDS Research and Human Retroviruses (2003), vol. 19(3), pp. 211-216.
Package insert for “Sustiva™ (efavirenz capsules) Rx Only”, Sep. 22, 1998, http://www.fda.gov/cder/foi/label/1998/20972lbl.pdf.
U.S. Department of Health and Human Services, For Immediate Release, Sep. 28, 1998, FDA Approves New Drug to Treat HIV, AIDS, http://www.fda.gov/bbs/topics/NEWS/NEW00654.html.
Meisel et al, “Synthese von 10-Substituierten 5,5-dimethyl-5,10-dihydro-benzo(B)(1,8)Naphthyridinen” vol. 39, No. 10, 1984, pp. 671-672, XP000986134.
Arvanitis Argyrios
Cocuzza Anthony J.
Patel Mona
Rodgers James D.
Wang Haisheng
Bristol-Myers Squibb Pharma
Coppins Janet L.
McKane Joseph K.
VanAtten Mary
LandOfFree
Tricyclic-2-pyridone compounds useful as HIV reverse... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tricyclic-2-pyridone compounds useful as HIV reverse..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic-2-pyridone compounds useful as HIV reverse... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3504184